PROFUSA, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
PROFUSA, INC. (PFSA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -17.62% for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-12-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2024-12-17
- PROFUSA, INC. effective income tax rate reconciliation, other adjustments, percent for the quarter ending 2024-09-30 was -17.62%.
- PROFUSA, INC. effective income tax rate reconciliation, other adjustments, percent for the quarter ending 2024-06-30 was -6.15%, a 345.02% decline year-over-year.
- PROFUSA, INC. effective income tax rate reconciliation, other adjustments, percent for the quarter ending 2024-03-31 was 2.69%, a 94.21% decline year-over-year.
- PROFUSA, INC. effective income tax rate reconciliation, other adjustments, percent for the quarter ending 2023-09-30 was -7.46%, a 413.45% decline year-over-year.
- PROFUSA, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 28.22%, a 334.15% increase from fiscal 2022.
- PROFUSA, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 6.50%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 3 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 6 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 8 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 9 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | -17.62% 10-Q · filed 2024-12-17 | -6.02% 10-Q · filed 2024-12-17 | ||||
| 2024-06-30 | -6.15% 10-Q · filed 2024-11-15 | 3.79% 10-Q · filed 2024-11-15 | ||||
| 2024-03-31 | 2.69% 10-Q · filed 2024-10-09 | |||||
| 2023-12-31 | 28.22% 10-K · filed 2024-02-26 | |||||
| 2023-09-30 | -7.46% 10-Q · filed 2024-12-17 | 7.46% 10-Q · filed 2023-11-20 | 31.74% 10-Q · filed 2024-12-17 | |||
| 2023-06-30 | 2.51% 10-Q · filed 2024-11-15 | 23.85% 10-Q · filed 2024-11-15 | ||||
| 2023-03-31 | 46.49% 10-Q · filed 2024-10-09 | |||||
| 2022-12-31 | 6.50% 10-K · filed 2024-02-26 | |||||
| 2022-09-30 | 2.38% 10-Q · filed 2023-11-20 | 1.03% 10-Q · filed 2023-11-20 | ||||
| 2022-06-30 | 2.14% 10-Q · filed 2023-08-14 | 0.54% 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-17 | |||||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |